Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma, T-Cell, Peripheral
×
Alemtuzumab
×
Clear all
Filters
3
NCT00646854
2019-03-01
ACT-1
University of Aarhus
Phase 3
Completed
136 enrolled